T-cell therapy for chemotherapy-refractory CMV infection.

被引：0
|
作者：
Einsele, H
Rufer, N
Roosnek, E
Hebart, H
Loeffler, J
Grigoleit, U
Kleihauer, A
Bruemmendorf, T
Riegler, S
Jahn, G
Sinzger, C
Kanz, L
机构：
[1] Univ Tubingen Hosp, Tubingen, Germany
[2] Univ Geneva, Hop Cantonal, CH-1211 Geneva, Switzerland
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2058
引用
收藏
页码：478A / 478A
页数：1
相关论文
共 50 条
  • [21] Use of a CMV Specific T Cell Immunity Assay in Late-Onset CMW Infection.
    Beaird, O.
    Carlson, M.
    Gaynor, P.
    Nanayakkara, D.
    Abdalla, B.
    Bunnapradis, S.
    Schaenman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 720 - 720
  • [22] Association of CMV-specific T-cell immunity and risk of CMV infection in lung transplant recipients
    Veit, Tobias
    Pan, Ming
    Munker, Dieter
    Arnold, Paola
    Dick, Andrea
    Kunze, Susanne
    Meiser, Bruno
    Schneider, Christian
    Michel, Sebastian
    Zoller, Michael
    Boehm, Stephan
    Walter, Julia
    Behr, Juergen
    Kneidinger, Nikolaus
    Kauke, Teresa
    CLINICAL TRANSPLANTATION, 2021, 35 (06)
  • [23] Current role of systemic therapy in transarterial chemotherapy-refractory hepatocellular carcinoma patients
    Kang, Hansung
    Lee, Hye Won
    INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, 2021, 10 (04): : 183 - 188
  • [24] Role of regulatory T cells in adoptive CMV-Specific T-Cell therapy
    Zwinger, Sandra
    Brestrich, Gordon
    Roemhild, Andy
    Maciejewski, Jaroslaw P.
    Kurtz, Andreas
    Reinke, Petra D.
    Volk, Hans D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 617 - 617
  • [25] T cell therapy of human CMV and EBV infection in immunocompromised hosts
    Riddell, SR
    Greenberg, PD
    REVIEWS IN MEDICAL VIROLOGY, 1997, 7 (03) : 181 - 192
  • [26] Apatinib Plus Radiation Therapy or Not in Chemotherapy-Refractory Recurrent or Metastatic Oral Squamous Cell Carcinoma: A Pilot Study
    Wu, H.
    Lu, X.
    Xu, J.
    Sun, X.
    Wang, S.
    Du, W.
    Liu, S.
    Li, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E358 - E358
  • [27] Metronomic chemotherapy for advanced and refractory cutaneous T-cell lymphoma treatment
    Lopez Aventin, D.
    Gallardo, F.
    Sanchez-Gonzalez, B.
    Pujol, R. M.
    Salar, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (01) : 136 - 138
  • [28] Chemotherapy response of refractory T-cell lymphoma in a patient with calpain deficiency
    Molina, J.
    Zarikian, S.
    Sagaseta de Ilurdoz, M.
    Alonso, A. Dura T. y
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 71 - 71
  • [29] CAR T-cell therapy for relapsed or refractory multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
  • [30] Cytomegalovirus antigen (CMV AG) screening to direct therapy for pediatric allogeneic stem cell transplant(alloSCT) patients at risk for CMV infection.
    Lehmann, LE
    Whyte, EA
    Russell, JD
    Spencer, S
    McIntosh, K
    Guinan, EC
    BLOOD, 1999, 94 (10) : 340A - 340A
12345